Laura Bukavina, MD, and Kyle Rose, MD, discuss some of the notable abstracts from the 2023 ASCO GU conference.
In this episode of Speaking of Urology®, Laura Bukavina, MD, MPH, and Kyle Rose, MD, discuss some of the notable abstracts that were presented at the American Society of Clinical Oncology (ASCO) Gastrourinary (GU) Cancers Symposium, which was held January 16-18, 2023 in San Francisco, California. Bukavina is a urologic oncology fellow at Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Rose is a urologic oncology fellow at Moffitt Cancer Center in Tampa, Florida.
This recap was originally presented by Dr. Bukavina and Dr. Rose during the inaugural live Twitter Spaces event held by Urology Times. In the discussion, Bukavina and Rose touched on the following abstracts:
Don’t forget to subscribe to Speaking of Urology® on Spotify, Apple Podcasts, or anywhere that podcasts are available.
Blue light cystoscopy decreases risk of recurrence, progression in NMIBC
May 9th 2024“The results of the BRAVO study performed within the VA health care system showed significant decreases in the risk of recurrence and progression, as well as the potential for improved overall survival in patients who received a BLC compared to patients who received WLC only,” says Stephen B. Williams, MD, MBA, MS, FACS, FACHE.